PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort

Clinical trial NCT07560215 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07560215
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Metastatic Prostate Cancer

Start date: 2026-04-30
Primary completion: 2027-03-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.